Vyome Biosciences raises $8 million from Sabre Partners, existing investors1 min read . Updated: 11 Aug 2014, 05:19 PM IST
The company will use the funds for advanced clinical research, development of better products, and innovative commercialization strategies
Vyome Biosciences, a New Delhi-based dermatology company, announced on Monday that it has raised $8 million in funding. This round of funding was led by Sabre Partners, with participation from existing investors Kalaari Capital and Aarin Capital.
Select your Category